Evidence map›Paper›PMID 18308592›Full record

ArticleImmunity2008

Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules.

Shaodong Dai, Eric S Huseby, Kira Rubtsova, James Scott-Browne, Frances Crawford, Whitney A Macdonald, Philippa Marrack, John W Kappler

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 166 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. The partitioning of TCR repertoires by thymic selection.The Journal of experimental medicine · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Structural plasticity in I-AFrontiers in immunology · 2022
    Article
  15. Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  16. Article
  17. MHC Restriction: Where Are We Now?Viral immunology · 2020
    Article
  18. Article
  19. Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shaodong DaiHoward Hughes Medical Institute and National Jewish Medical and Research Center, Denver, CO 80206, USA.
Eric S Huseby
Kira Rubtsova
James Scott-Browne
Frances Crawford
Whitney A Macdonald
Philippa Marrack
John W Kappler
Howard Hughes Medical Institute · USNational Jewish Health · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
REGULATORY MECHANISMS IN THE IMMUNE SYSTEMR01AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 1985 to 2006
$1.6M
Control of Chemokine Production by Memory T CellsR01AI052225 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2002 to 2006
$1.3M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Regulatory Mechanisms in the Immune SystemR56AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 2007 to 2007
$321k
REGULATORY MECHANISMS IN THE IMMUNE SYSTEMR37AI017134 · NIAID · NATIONAL JEWISH HEALTH · PI KAPPLER, JOHN W · 1987 to 1996
–
Howard Hughes Medical InstituteNIAID NIH HHS AI-17134NIAID NIH HHS AI-18785NIAID NIH HHS AI-22295NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI017134NIAID NIH HHS R01 AI018785NIAID NIH HHS R01 AI052225NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI017134NIAID NIH HHS R56 AI018785
6 · The paper itself

Abstract

To test whether highly crossreactive alphabeta T cell receptors (TCRs) produced during limited negative selection best illustrate evolutionarily conserved interactions between TCR and major histocompatibility complex (MHC) molecules, we solved the structures of three TCRs bound to the same MHC II peptide (IAb-3K). The TCRs had similar affinities for IAb-3K but varied from noncrossreactive to extremely crossreactive with other peptides and MHCs. Crossreactivity correlated with a shrinking, increasingly hydrophobic TCR-ligand interface, involving fewer TCR amino acids. A few CDR1 and CDR2 amino acids dominated the most crossreactive TCR interface with MHC, including Vbeta8 48Y and 54E and Valpha4 29Y, arranged to impose the familiar diagonal orientation of TCR on MHC. These interactions contribute to MHC binding by other TCRs using related V regions, but not usually so dominantly. These data show that crossreactive TCRs can spotlight the evolutionarily conserved features of TCR-MHC interactions and that these interactions impose the diagonal docking of TCRs on MHC.

Indexed as

Amino Acid SequenceAnimalsAntigen PresentationConserved SequenceCross ReactionsHistocompatibility Antigens Class IIHumansLymphocyte ActivationProtein Structure, QuaternaryReceptors, Antigen, T-Cell, alpha-betaSurface Plasmon ResonanceT-LymphocytesHistocompatibility Antigens Class IIReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID18308592
PMCPMC2287197
OpenAlexW2053472272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.